Prenetics Global Ltd
For the period ended Nov 13, 2025. Filed Nov 13, 2025.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Nov 13, 2025 · Filed Nov 13, 2025
Use the contents to explore the available documents and sections.
Contents
EXPLANATORY NOTE
Prenetics Global Limited (the "Company"), a leading health sciences company and parent of the IM8 premium health and longevity brand, furnishes this Form 6-K to announce that on November 12, 2025 its Chief Marketing Officer, Rahul Ramchand, purchased 30,000 shares of the Company's Class A Ordinary Shares at a price of $13.17 per share in the open market for a total purchase price of $395,151, bringing his total holdings to 45,553 Class A Ordinary Shares.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.